Navigation Links
James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Date:4/15/2008

PITTSBURGH, April 15 /PRNewswire/ -- Pittsburgh-based Foundation Radiology Group (FRG), a full-service radiology provider which uses board-certified radiologists to interpret diagnostic images for hospitals announced today that James W. Backstrom, M.D., has been appointed to the position of Chief Medical Officer. The appointment is another step in FRG's development of a nationwide network of radiology physician groups to provide hospitals, imaging centers and other clients with 24/7/365 diagnostic imaging services.

Dr. Backstrom is currently the President of the Pittsburgh Roentgen Society (PRS) and was previously a member of Lucien Diagnostic Imaging. While affiliated with Lucien, he served in a wide variety of management capacities, including Director of Pediatric Services, Physician Marketing Coordinator, Director of Armstrong Outpatient Imaging Center and Chairman of Radiology for Armstrong County Memorial Hospital. Additionally he was a member of Lucien's Board of Directors from 2003 to 2006. Prior to arriving in Pittsburgh, Dr. Backstrom was a member of the Board of Directors for Advanced Radiology Services in Grand Rapids, Michigan and participated in a series of group mergers which helped to change the face of radiology in western Michigan. Dr. Backstrom brings over 20 years of experience combining, world-class radiology care with innovative and compassionate patient care solutions.

"We are pleased to have Dr. Backstrom join our leadership team," said Brandon W. Chan, Chief Executive Officer of Foundation Radiology Group. "Dr. Backstrom will be instrumental in our mission to build the preeminent national diagnostic imaging and radiology service bureau. His experience and prominence within our industry will be invaluable to us as we grow our client base and expand our subspecialty expertise. Dr. Backstrom will lead our efforts in managing our ongoing radiology client relations, clinical quality assurance, and our industry relations campai
'/>"/>

SOURCE Foundation Radiology Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
2. Orchid Cellmark Appoints James F. Smith Chief Financial Officer
3. Immunotec Inc. announces appointment of President & CEO James A. Northrop
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. James Webb Space Telescope marks successful completion
6. IRIDEX Announces James Mackaness Will Be Chief Financial Officer
7. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
8. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
9. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
10. Warner Chilcott Reports the Death of Its Director James Andress
11. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TS...d that John Docherty, president and chief operatin...6th annual Investor Summit on November 10, 2009 at...r. Docherty will provide an overview of the Compan...nd Topical Interferon Alpha-2b. The slide show po...
(Date:11/6/2009)... ,, 3Q09 Corporate...a(TM) E.U. Marketing Authorization to Astellas Pha...mercial readiness activities Expanded management ...ng; and Director, Commercial Operations Appointed...t Committee chairman , Upcoming 2009 Milest...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... GenVec, Inc. (Nasdaq: ...he third quarter ended September 30, 2009. GenVec ...re) for the three months ended September 30, 2009 ...share) in the comparable quarter of 2008. For the ... loss was $14.1 million ($0.15 per share), compare...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ns, and great differences among countries. This i...to use previously collected samples from biobanks ...xtremely complicated to carry out major internatio...hnology, Swedish ethics researchers at the Center ... researchers, put forward a pioneering solution: a...
...w kind of biosensor can tell., A new and deceptiv...s at Vanderbilt University that can measure the in...ical molecules including proteins, sugars, antibod...capability needed to capitalize on the new avenues...ar-plus effort to sequence the human genome. DNA i...
...ound that the body,s innate ability to adapt to re...effective and less costly artificial respirators. ...nduced sedation or paralysis currently necessary f...associative learning, or our innate ability to ada...e described in the September 12 issue of PLoS ONE,...
Other Biology Technology:Long-awaited international ethical guidelines for biobank researchers 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 3MIT: Leveraging learning for artificial respiration 2
(Date:11/9/2009)...ing Harbor, N.Y. Oncologists have had their hands...have mutations that disable a protein called p53. ...s several cancer-fighting operations within cells.... often cannot be treated. , These tumors might ...ew study from Cold Spring Harbor Laboratory (CSHL)...
(Date:11/9/2009)...versity evolutionary biologists David Queller and ...peration and low conflict between components, from..."organismality," whether that thing is an animal, ...traits scientists use to describe an organism, suc...species, may not be necessary to achieve organisma...
(Date:11/9/2009)...f academic, government and industry researchers ha...esculenta) genome. The project is an important fir...is subsistence crop and addressing some of the man... world. , Cassava is a root crop that serves as ...people each day. Although it has many properties t...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Injection May Heal Damaged Heart 52560 1Injection May Heal Damaged Heart 52560 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 1National Science Foundation Announces 2420M Research Award to South Carolina 52556 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 3More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 1More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 2
...) In an epidemiological study, Tufts University re...in a sample of the United States population based...LP) levels in the bloodstream. Plasma PLP is the i... current Recommended Dietary Allowance (RDA) of vi...function and important for maintaining a healthy i...
...reproduce, like all vertebrates, they either lay t... according to new research by a team of Boston Uni...ropsophus ebraccatus) in Panama that reproduces bo...ecision to lay egg masses aquatically in a pond or...ond, where the newly-hatched tadpoles simply fall ...
...quality at beaches along the Great Lakes have prom... safe for recreation. A new collaborative project ...rs when they are faced with deciding whether to cl...rative effort will draw on the expertise of U.S. G...l agencies. , The project has been funded throug...
Other Biology News:Study identifies trends of vitamin B6 status in US population sample 2Study identifies trends of vitamin B6 status in US population sample 3Reproductive plasticity revealed: Neotropical treefrog can choose to lay eggs in water or on land 2To swim or not to swim? 2
ProtoArray Kinase Substrate Identification Application Kit from Invitrogen
Yeast Extract Solution from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
Biology Products: